Xenetic Biosciences, Inc. (XBIO) Income Statement 2011 - 2025

Xenetic Biosciences, Inc.

NasdaqCM:XBIO

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

Location

United States

Market Cap

USD 6.08 M

Share Price

USD 3.94

Avg Daily Volume

8,263

Change (1 day)

5.07%

Change (1 year)

-3.90%

Change (YTD)

-1.25%

Xenetic Biosciences, Inc. Income Statement 2015 - 2025

This table shows the Income Statement for Xenetic Biosciences, Inc. going from 2015 until 2025. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.